Biogen Pharmachem Industries
BSE 531752
2 stories, newest first.
- Board meeting on 3 November 2026 to approve unaudited Q2 and half-year results
- Biogen Pharmachem Industries Ltd shareholder sells 4.04% stake, holding falls to 00%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.